GSD NovaType III SARS-CoV-2 (1x96 reactions)

GSD NovaType III SARS-CoV-2 (1x96 reactions)

GSD NovaType Select Base SARS-CoV-2 RT-PCR (1x96)

GSD NovaType Select Base SARS-CoV-2 RT-PCR (1x96)

GSD NovaType III SARS-CoV-2 (4x96 reactions)

CE-IVD marked Multiplex RT-PCR Assay for the qualitative detection and discrimination of relevant mutations associated with SARS-CoV-2 variants: B.1.427 / B.1.429 (Epsilon), / B.1.617.2 (Delta), B.1.617.1 (Kappa) / B.1.617.3, B.1.351 (Beta) / P.1 (Gamma).

The assay is intended as a confirmatory test for detection of concerning RNA mutations within the S gene of the SARS-CoV-2 genome that are suspected to affect efficacy of vaccination or transmissibility of the virus.

Not available in the US.

CE-IVD marked Multiplex RT-PCR Assay for the qualitative detection and discrimination of relevant mutations associated with SARS-CoV-2 variants: B.1.427 / B.1.429 (Epsilon), / B.1.617.2 (Delta), B.1.617.1 (Kappa) / B.1.617.3, B.1.351 (Beta) / P.1 (Gamma).

• Confirmatory test for detection of new emerging mutations
• Parallel discrimination between S gene 484 wildtype (E484) and mutations E484K, E484Q, and L452R
• Specimen types: nasal lavage/smear, nasopharyngeal lavage/smear, oropharyngeal swab
• Validated PCR platforms: AriaMxTM and AriaDxTM (Agilent Technologies); additional thermal cyclers currently under validation
• Fast and reliable results with very high sensitivity
• CE-IVD

The assay is intended as a confirmatory test for detection of concerning RNA mutations within the S gene of the SARS-CoV-2 genome that are suspected to affect efficacy of vaccination or transmissibility of the virus and can be for example found in the following SARS-CoV-2 lineages:

Mutation Lineages First Detected WHO label
E484K

B.1.351(20H/501Y.V2)
B.1.1.28 (P.1;20J/501Y.V3)

South Africa
Brazil
Beta
Gamma
E484Q B.1.617 (G/452.V3) India Delta
L452R

B.1.427 / B.1.429 (CAL.20C)
B.1.617.1

USA
India
Epsilon
Kappa

 

Not available in the US.

More Information
SKU PCOV6094T
No. of tests 4 x 96
Specificity Nasal lavage/smear, nasopharyngeal lavage/smear, oropharyngeal swab
PCR cycler platforms AriaMxTM and AriaDxTM (Agilent Technologies)

Test Instructions